REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sunbio, Inc. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Sunbio, Inc. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sunbio, Inc. is engaged in developing of biosimilars, biopharmaceuticals as well as medical devices. The company offers products such as a variety of PEG products including PEG-filgrastim, mPEG-acrylate, mPEG-epoxide and other related products. Sunbio, Inc. was incorporated in 1997 and is based in Gunpo, South Korea.

Headquarters
95, Sanbon-Rogunpo
Gunpo; Gyeonggi;

Contact Details: Purchase the Sunbio, Inc. report to view the information.

Website: http://www.sunbio.com

Basic Information
Total Employees:
Purchase the Sunbio, Inc. report to view the information.
Outstanding Shares:
Purchase the Sunbio, Inc. report to view the information.
Registered Capital:
Purchase the Sunbio, Inc. report to view the information.
Financial Auditors:
Purchase the Sunbio, Inc. report to view the information.
Incorporation Date:
June 10, 1997
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
30.5%
Purchase this report to view the information.
5.6%
Purchase this report to view the information.
1.5%
Subsidiaries
선바이오(주)
Company Performance
Financial values in the chart are available after Sunbio, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
65.65%▲
Total operating revenue
65.54%▲
Operating profit (EBIT)
2539.4%▲
EBITDA
513.23%▲
Net Profit (Loss) for the Period
429.92%▲
Total assets
11.11%▲
Total equity
17.9%▲
Operating Profit Margin (ROS)
39.61%▲
Net Profit Margin
25.76%▲
Return on Equity (ROE)
12.74%▲
Quick Ratio
-0.22%▼
Cash Ratio
0.25%▲

Similar companies

Hk Inno.N Corporation
 
Sk Bio Science Co.,Ltd.
H.Pio Co.,Ltd
 
Green Cross Well Being Corporation
Korea Pharma Co.,Ltd.
 
Withus Pharmaceutical. Co.,Ltd.
Genolution Inc.
 
Medizen Humancare Inc Co. Ltd.
Toolgen Incorporated
 
Angiolab Inc.
Prestige Biologics Co., Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo